Skip to content
OpenCapital
Get started

Cronos Group CRON Cannabis extracts — Net revenue

Other product segments

Cannabis flower
$33.73M+44.5%

Similar metrics at other companies

Evommune logo
EVMNHemp Derived Products — Revenue
$6.27K-91.0%
Westrock Coffee Company logo
WESTFlavors Extracts And Ingredients — Revenue
$62.61M+44.8%
Altria Group logo
MOSmokeable Products — Net revenues
$4.76B+2.9%
Evommune logo
EVMNNutraceuticalsupplements — Revenue
$1.64M+7.8%
Ardelyx logo
ARDXProduct sales, net — Total revenues
$93.37M+37.7%
Jazz Pharmaceuticals logo
JAZZProduct sales, net — Revenue from Contract with Customer, Excluding Assessed Tax
$1.03B+22.1%

Other financials

Income statement

See full
Revenue$45.2M+40.1%
Gross profit$19.2M+39.5%
Operating income-$1.8M+55.0%
Net income$13.8M+125%
EPS (diluted)$0.04+100%

Balance sheet

See full
Cash & equivalents$821.9M+3.0%
Total debt$1.3M-27.8%
Total equity$1.1B+0.7%
Total assets$1.2B+1.6%

Cash flow

See full
Operating cash flow$10.9M+620%
CapEx$1.9M-87.7%
Free cash flow$9.0M+152%

Valuation

See full
Market cap$1.01B+41.3%
Enterprise value$192.08M-343%
P/S6.4×+0.6×

Profitability

See full
Gross margin42.7%+15.1pp
Operating margin-9.5%-4.3pp
Net margin-1.1%-40.8pp
FCF margin16.6%+13.3pp

Returns & leverage

See full
Return on equity-0.2%-4.8pp
Debt / equity0×0.0×
Current ratio21.9×-5.9×

Where this comes from

Reported directly by Cronos Group in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cronos Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cronos Group's cannabis extracts — net revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cronos Group's cannabis extracts — net revenue?
Cronos Group (CRON) reported cannabis extracts — net revenue of $11.46M in Q1 2026.
How has Cronos Group's cannabis extracts — net revenue changed year-over-year?
Cronos Group's cannabis extracts — net revenue increased by 33.1% year-over-year, from $8.61M to $11.46M.
What is the long-term trend for Cronos Group's cannabis extracts — net revenue?
Over 3 years (2022 to 2025), Cronos Group's cannabis extracts — net revenue has grown at a 60.4% compound annual growth rate (CAGR), from $9.14M to $37.7M.
What does cannabis extracts — net revenue mean?
This metric represents the total revenue generated from the sale of cannabis extract products after accounting for returns, discounts, and allowances. It serves as a key indicator of the market demand and commercial success of a company's concentrated cannabis product portfolio. Tracking this figure helps investors evaluate the growth trajectory and competitive positioning of the extracts segment relative to broader product offerings.